COLIZZI, Marco
 Distribuzione geografica
Continente #
AS - Asia 3.778
NA - Nord America 2.009
EU - Europa 1.225
SA - Sud America 686
AF - Africa 63
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.772
Nazione #
SG - Singapore 2.426
US - Stati Uniti d'America 1.896
BR - Brasile 568
IT - Italia 494
CN - Cina 488
HK - Hong Kong 369
VN - Vietnam 228
RU - Federazione Russa 208
DE - Germania 102
IE - Irlanda 96
GB - Regno Unito 57
CA - Canada 56
KR - Corea 56
IN - India 55
AR - Argentina 47
FI - Finlandia 41
NL - Olanda 39
AT - Austria 36
BD - Bangladesh 36
MX - Messico 36
FR - Francia 25
EC - Ecuador 24
ES - Italia 22
ID - Indonesia 20
DK - Danimarca 19
PL - Polonia 19
TR - Turchia 18
CO - Colombia 17
BE - Belgio 13
TG - Togo 12
ZA - Sudafrica 12
IL - Israele 11
JP - Giappone 11
PK - Pakistan 10
IQ - Iraq 9
MA - Marocco 9
SE - Svezia 9
UZ - Uzbekistan 8
AU - Australia 7
CL - Cile 7
PY - Paraguay 7
CZ - Repubblica Ceca 6
EG - Egitto 6
JO - Giordania 6
RS - Serbia 6
VE - Venezuela 6
PA - Panama 5
UA - Ucraina 5
BG - Bulgaria 4
CH - Svizzera 4
CR - Costa Rica 4
DZ - Algeria 4
ET - Etiopia 4
HU - Ungheria 4
PE - Perù 4
TN - Tunisia 4
AO - Angola 3
GY - Guiana 3
HN - Honduras 3
LK - Sri Lanka 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
RO - Romania 3
BN - Brunei Darussalam 2
IR - Iran 2
JM - Giamaica 2
KE - Kenya 2
KZ - Kazakistan 2
LB - Libano 2
MU - Mauritius 2
PH - Filippine 2
SA - Arabia Saudita 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GN - Guinea 1
GR - Grecia 1
KG - Kirghizistan 1
LC - Santa Lucia 1
LV - Lettonia 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
Totale 7.767
Città #
Singapore 504
Hong Kong 366
Beijing 250
Chandler 250
Ashburn 238
Boardman 139
Dublin 94
Ho Chi Minh City 93
Los Angeles 90
Princeton 84
Dallas 82
São Paulo 61
Milan 60
Hefei 56
Redondo Beach 56
Seoul 56
Rome 54
Buffalo 47
Hanoi 44
Toronto 39
Andover 30
Trieste 29
Nuremberg 26
Chicago 22
New York 22
The Dalles 22
Hyderabad 21
Lappeenranta 21
Vienna 21
Ogden 20
Santa Clara 20
Copenhagen 18
Frankfurt am Main 18
Munich 18
Düsseldorf 16
Rio de Janeiro 16
Brooklyn 15
Denver 15
Helsinki 15
Mexico City 15
Warsaw 14
Brasília 13
Brussels 13
Ningbo 13
Lomé 12
Udine 12
Venice 11
Atlanta 10
Council Bluffs 10
Haiphong 10
Istanbul 10
Porto Alegre 10
Portsmouth 10
Tokyo 10
Verona 10
Amsterdam 9
Campinas 9
Montreal 9
Naples 9
Stockholm 9
Boston 8
Curitiba 8
Guayaquil 8
Johannesburg 8
Poplar 8
Seattle 8
Can Tho 7
Dhaka 7
London 7
Mumbai 7
Orem 7
Quito 7
Shanghai 7
Spinea 7
Tashkent 7
Belluno 6
Belo Horizonte 6
Bergamo 6
Chennai 6
Da Nang 6
Florence 6
Guangzhou 6
Guarulhos 6
Porcia 6
Pune 6
Ribeirão Preto 6
Santo André 6
São Bernardo do Campo 6
Tel Aviv 6
Treviso 6
Turin 6
Ankara 5
Belgrade 5
Charlotte 5
Columbus 5
Dongguan 5
Houston 5
Hải Dương 5
Lauterbourg 5
Lonato 5
Totale 3.528
Nome #
Therapeutic Effect of Palmitoylethanolamide in Cognitive Decline: A Systematic Review and Preliminary Meta-Analysis of Preclinical and Clinical Evidence 252
Lessons learnt while designing and conducting a longitudinal study from the first Italian COVID-19 pandemic wave up to 3 years 250
Prenatal insomnia disorder may predict concurrent and postpartum psychopathology: A longitudinal study 187
Occupational Stress Among Italian Postgraduate Medical Trainees: A Pilot Study for the Validation of the SCOPE Questionnaire 178
Challenges in addressing youth mental health 174
In Web We Trust: The Promised Cannabidiol Effects on Obesity as a Matter of Language and Marketing on Webpages 173
Impact of COVID-19 on behavior in autism spectrum disorder 171
Mental health symptoms one year after acute COVID-19 infection: prevalence and risk factors 103
The Supplementation Therapy in Autism and Response to Treatment (START) Study: An Open-Label Feasibility Trial of Ultramicronized Palmitoylethanolamide Potential to Alleviate Psychic Distress among Autistic Adults 99
Cannabis Use in Autism: Reasons for Concern about Risk for Psychosis 84
Feigning Capgras Syndrome and Developmental Prosopagnosia: a rare case of Pediatric Factitious Disorder 81
Mentalization in young patients undergoing opioid agonist treatment: Implications for clinical management 79
Disturbi d’ansia 78
21.5 Repercussions of the First and Second COVID-19 Waves in the Italian Pediatric Population: An Inpatient Psychiatric Emergency Study 77
51.18 THE COVID-19 OUTBREAK IMPACT ON WELL-BEING AMONG PEOPLE WITH AUTISM SPECTRUM DISORDER IN ITALY: AN N = 527 WEB-BASED SURVEY 77
CaReL Guideline: A Consensus-Based Guideline on Case Reports and Literature Review (CaReL) 75
4.4 IS ALTERED SENSORIMOTOR INTEGRATION A CORE FEATURE OF TOURETTE'S DISORDER? A CASE-CONTROL STUDY 75
COVID-19-induced neuropsychiatric symptoms can persist long after acute infection: a 2-year prospective study of biobehavioral risk factors and psychometric outcomes 72
Cannabis use and the development of tolerance: a systematic review of human evidence 70
Editorial: Case reports in autism 69
COVID-19 Survivors Are Still in Need of Neuropsychiatric Support Two Years after Infection 69
The 2019 Schizophrenia International Research Society Conference, 10–14 April, Orlando, Florida: A summary of topics and trends 69
Assessing the biobehavioral effects of ultramicronized-palmitoylethanolamide monotherapy in autistic adults with different severity levels: a report of two cases 68
Is It Time to Test the Antiseizure Potential of Palmitoylethanolamide in Human Studies? A Systematic Review of Preclinical Evidence 67
Confirmation of increased and more severe adolescent mental health-related in-patient admissions in the COVID-19 pandemic aftermath: A 2-year follow-up study 66
Palmitoylethanolamide and its biobehavioral correlates in autism spectrum disorder: A systematic review of human and animal evidence 66
Cannabis and cognition: Connecting the dots towards the understanding of the relationship 65
Adolescent lifestyle behaviors, coping strategies and subjective wellbeing during the covid-19 pandemic: An online student survey 63
Can we interrogate public databases to fill critical gaps in mental health epidemiology? Testing the association between cannabis and psychosis in the UK as an example 62
Associations between psychosis endophenotypes across brain functional, structural, and cognitive domains 61
Effectiveness of equine-assisted activities and therapies for improving adaptive behavior and motor function in autism spectrum disorder 61
The Autism–Psychosis Continuum Conundrum: Exploring the Role of the Endocannabinoid System 61
Questioning the role of palmitoylethanolamide in psychosis: a systematic review of clinical and preclinical evidence 60
Neurobiological underpinnings of the effects of cannabinoids 60
Attachment styles in transsexual patients and clinical and nonclinical control groups: A Response 60
A prediction modelling and pattern detection approach for the first-episode psychosis associated to cannabis use 60
Additional evidence for neuropsychiatric manifestations in mosaic trisomy 20: A case report and brief review 59
Association of cannabis with glutamatergic levels in patients with early psychosis: Evidence for altered volume striatal glutamate relationships in patients with a history of cannabis use in early psychosis 59
Childhood trauma and being at-risk for psychosis are associated with higher peripheral endocannabinoids 59
Biobehavioral Interactions between Endocannabinoid and Hypothalamic-pituitary-adrenal Systems in Psychosis: A Systematic Review 58
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence 56
Tic-Related Obsessive-Compulsive and Eating Disorders in Dandy-Walker Variant: A Case Report and Systematic Reappraisal of Psychiatric Profiles 56
The influence of risk factors on the onset and outcome of psychosis: What we learned from the GAP study 55
Further evidence on the interplay between benzodiazepine and Z-drug abuse and emotion dysregulation 55
Evidence for endocannabinoid-like compound supplementation for human health 54
Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study 54
Post-COVID-19 Syndrome as Described by Patients: A Qualitative Study 54
Palmitoylethanolamide supplementation for human health: A state-of-the-art systematic review of Randomized Controlled Trials in patient populations 54
Cannabis and psychosis: What do we know and what should we do? 54
Clinical heterogeneity of feeding and eating disorders: using personality psychopathology to differentiate “simplex” and “complex” phenotypes 53
Where Do Neurodevelopmental Disorders Go? Casting the Eye Away from Childhood towards Adulthood 51
Lessons Learnt From Running a Transition-Age Youth Mental Health Outpatient Clinic in Italy: The PRecocity of Intervention in Adolescent Medicine (PRIMA) Experience 51
Validation of the Collaborative Outcomes study on Health and Functioning during Infection Times (COH-FIT) questionnaire for adults 51
Expert consensus riguardante cannabis, cannabinoidi e prodotti derivati 51
The collaborative outcomes study on health and functioning during infection times in adults (COH-FIT-Adults): Design and methods of an international online survey targeting physical and mental health effects of the COVID-19 pandemic 51
Medically unexplained symptoms in the times of COVID-19 pandemic: A case-report 51
Prevention in Mental Health: From Risk Management to Early Intervention 50
Un adolescente con insolita sintomatologia ai tempi del COVID-19 50
Editorial: Methods and applications in addiction psychiatry research: 2021 50
Psychological Support, Puberty Suppression, and Psychosocial Functioning in Adolescents with Gender Dysphoria 50
Concomitant psychiatric problems and hormonal treatment induced metabolic syndrome in gender dysphoria individuals: A 2year follow-up study 50
Sociodemographic and clinical changes in pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic: March 2020 to June 2021 50
Pediatric emergency department mental health assessments in the 2 years following the COVID-19 outbreak reveal higher vulnerability for eating disorder and suicide risk 49
The effectiveness of lurasidone add-on for residual aggressive behavior and obsessive symptoms in antipsychotic-treated children and adolescents with tourette syndrome: Preliminary evidence from a case series 49
Prevalence and risk factors for depression in factitious disorder: a systematic review 48
Collaborative outcomes study on health and functioning during infection times (COH-FIT): Insights on modifiable and non-modifiable risk and protective factors for wellbeing and mental health during the COVID-19 pandemic from multivariable and network analyses 47
The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis 47
Cannabis and Psychosis 46
Psico-oncologia e psichiatria in medicina palliativa 46
Global and risk-group stratified well-being and mental health during the COVID-19 pandemic in adults: Results from the international COH-FIT Study 46
Investigating gait, movement, and coordination in children with neurodevelopmental disorders: Is there a role for motor abnormalities in atypical neurodevelopment? 46
Poster #M195 THE INTERACTION BETWEEN CNR1 GENETIC VARIATION AND CANNABIS EXPOSURE PREDICTS PREFRONTAL FUNCTIONAL CONNECTIVITY AND BEHAVIOR DURING WORKING MEMORY 46
Cannabis users are less sensitive to the acute psychotomimetic effects of delta-9-tetrahydrocannabinol administration 46
Jumping to conclusions at first onset of psychosis predicts longer admissions, more compulsory admissions and police involvement over the next 4 years: the GAP study 46
Psychological factors associated with vaccination hesitancy: an observational study of patients hospitalized for COVID-19 in a later phase of the pandemic in Italy 45
Postural control in childhood: Investigating the neurodevelopmental gradient hypothesis 45
Changes in Revolving-Door Mental Health Hospitalizations during the COVID-19 Pandemic: A 5-Year Chart Review Study 45
Risk of psychosis in autism spectrum disorder individuals exposed to psychosocial stressors: A 9-year chart review study 44
Effect of cannabis on glutamate signalling in the brain: A systematic review of human and animal evidence 44
Transsexual patients' psychiatric comorbidity and positive effect of cross-sex hormonal treatment on mental health: Results from a longitudinal study 44
Cannabis: Neuropsychiatry and its effects on brain and behavior 44
Neurodevelopmental Disorders and Psychosocial Issues Later in Life 43
Cannabidiol (CBD) Listed as a Drug of Abuse by the Italian Health Ministry: Expert Opinion 43
The Moderating Role of Genetic and Environmental Risk Factors for Schizophrenia on the Relationship between Autistic Traits and Psychosis Expression in the General Population 43
Poster #35 STUDYING EPISODIC MEMORY CEREBRAL NETWORK: A NOVEL EVENT-RELATED TASK FOR FMRI 43
Differential gene expression analysis in blood of first episode psychosis patients 43
Collaborative Outcomes Study on Health and Functioning During Infection Times (COH-FIT): Global and Risk-Group Stratified Course of Well-Being and Mental Health During the COVID-19 Pandemic in Adolescents 42
Vortioxetine Add-On to Methylphenidate for the Treatment of Symptoms of Sickness Behavior in Attention-Deficit Hyperactivity Disorder: Report of Two Cases 42
Poster #103 INTERACTION BETWEEN COMT GENOTYPE, CANNABIS USE, AND BFQ MEASURES OF SOCIABILITY 42
The Relationship Between Dissociative Experiences and Cannabis Use: a Systematic Review 42
Psychological Interventions Tailored to the Needs of Individuals With Hearing and Visual Impairments: What Do We Know and What Should We Do? A Commentary on “A Systematic Review and Meta-Analysis of Psychological Interventions for Persons With Hearing or Vision Impairment: Research Gaps and Call to Action” 41
Hyperprolactinaemia in first episode psychosis - A longitudinal assessment 41
The Neural Substrate of Reward Anticipation in Health: A Meta-Analysis of fMRI Findings in the Monetary Incentive Delay Task 41
Epigenetic Regulation and Genetic Variation of AKT1 Predict Prefrontal Physiology 41
Interaction between functional genetic variation of DRD2 and cannabis use on risk of psychosis 41
COGNITIVE DEFICITS AS INTERMEDIATE PHENOTYPE IN SCHIZOPHRENIA 41
Longitudinal assessment of the effect of cannabis use on hospital readmission rates in early psychosis: A 6-year follow-up in an inpatient cohort 41
Lo stigma nella salute mentale 41
Introduction 40
Effects of short-term cannabidiol treatment on response to social stress in subjects at clinical high risk of developing psychosis 40
Totale 6.492
Categoria #
all - tutte 45.918
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.918


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022463 0 0 0 0 0 0 92 175 0 0 41 155
2022/2023745 87 13 27 88 63 177 34 56 93 35 43 29
2023/2024458 47 40 14 12 29 20 37 91 42 44 41 41
2024/20253.796 106 151 146 99 85 184 214 190 347 258 900 1.116
2025/20262.774 451 470 493 590 729 41 0 0 0 0 0 0
Totale 8.236